Cargando...
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Immune checkpoint inhibitors (ICIs) have become a promising immunotherapy for cancers. Human leukocyte antigen-G (HLA-G), a neoantigen, its biological functions and clinical relevance have been extensively investigated in malignancies, and early clinical trials with “anti-HLA-G strategy” are being l...
Guardado en:
| Publicado en: | Front Immunol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8278316/ https://ncbi.nlm.nih.gov/pubmed/34276691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.698677 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|